Table 2.
Variable |
At screening*
|
At 6 months†
|
Levonorgestrel at 12 months | |||
---|---|---|---|---|---|---|
Control group | Levonorgestrel | Control group | Levonorgestrel | |||
General wellbeing | 87 (77 to 92) | 90 (74 to 94) | 79 (64 to 87) | 24 (14 to 40) | 10 (4 to 29) | |
Work performance | 75 (61 to 80) | 79 (62 to 89) | 76 (54 to 87) | 20 (5 to 35) | 6 (3 to 11) | |
Physical activity | 78 (64 to 92) | 88 (64 to 95) | 78 (55 to 88) | 27 (9 to 38) | 10 (3 to 28) | |
Sex life | 66 (52 to 80) | 68 (49 to 86) | 66 (51 to 85) | 36 (17 to 49) | 8 (3 to 28) | |
Leisure time activty | 74 (64 to 85) | 76 (54 to 86) | 74 (54 to 86) | 11 (5 to 27) | 6 (3 to 29) |
At screening there were no significant differences between groups.
At 6 months all differences between groups were significant (P=0.002 for sex life and P<0.001 for all other variables).